FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...

Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...

AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

Schizophrenia, a psychiatric disorder that affects how a person feels, thinks, and behaves, affects roughly 1% of the population (approximately 3.5 million people in the U.S.) and is a leading cause ...

In a groundbreaking study, scientists from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) have ...

Researchers from Indiana University Health and the IU School of Medicine have developed a new molecular test capable of detecting three major pathogenic fungi at once — and with a much quicker ...

Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at the 2025 Association for Molecular ...

The field of cancer research has increasingly focused on the intricate interplay between regulated cell death (RCD) pathways and the immune microenvironment in tumor progression and treatment.